sign free newsletters sign free newsletters gene therapy vision loss initially cost $ 850,000 gene therapy u.s. treat rare inherited form blindness price tag $ 850,000 makes treatment called luxturna spark therapeutics expensive medicine sold u.s. ranked sticker price spark ceo jeff marrazzo says luxturna ability restore vision small number people defective gene justifies high cost particularly gene therapy injected time eye long term benefit investors luxturna actual price considered bargain feel like right middle ground decision marrazzo said interview balancing company desire capture economic value luxturna ensuring patients access therapy smooth reimbursement mute inevitable criticism price spark wednesday announced